World Library  
Flag as Inappropriate
Email this Article

Serotonin antagonist and reuptake inhibitor

Article Id: WHEBN0025128506
Reproduction Date:

Title: Serotonin antagonist and reuptake inhibitor  
Author: World Heritage Encyclopedia
Language: English
Subject: Antidepressant, GABA reuptake inhibitor, Alcoholic beverage, 5-Hydroxytryptophan, Volinanserin
Collection: Antidepressants
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Serotonin antagonist and reuptake inhibitor

Chemical structure of the serotonin antagonist and reuptake inhibitor trazodone.

Serotonin antagonist and reuptake inhibitors (SARIs) are a class of drugs used mainly as antidepressants, but also as anxiolytics and hypnotics. They act by antagonizing serotonin receptors such as 5-HT2A and inhibiting the reuptake of serotonin, norepinephrine, and/or dopamine. Additionally, most also act as α1-adrenergic receptor antagonists. The majority of the currently marketed SARIs belong to the phenylpiperazine class of compounds.

Contents

  • List of SARIs 1
  • Pharmacology 2
    • Binding profile 2.1
  • See also 3
  • References 4

List of SARIs

Vilazodone is a related drug but does not fit into this class as it does not function as a serotonin antagonist, acting as a 5-HT1A receptor partial agonist instead.

Niaprazine is also related to this group but does not inhibit the reuptake of serotonin or the other monoamines.

Pharmacology

Binding profile

The affinities (Kd (nM)) of a selection of SARIs have been compared below at an assortment of binding sites:[1][2][3][4]

Compound SERT NET DAT 5-HT1A 5-HT2A α1 α2 D2 H1 mACh
Etoperidone 890 20,000 52,000 85 36 38 570 2,300 3,100 >35,000
Nefazodone 200 360 360 80 26 48 640 910 24,000 11,000
Trazodone 160 8,500 7,400 78 16 39 405 3,650 725 324,000

The selected ligands act as antagonists (or inverse agonists depending on the site in question) at all receptors listed except at 5-HT1A where they are partial agonists,[5] and as inhibitors of all transporters listed.[1][2][3][4]

See also

References

  1. ^ a b Tatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology 340 (2–3): 249–58.  
  2. ^ a b Wander TJ, Nelson A, Okazaki H, Richelson E (December 1986). "Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro". European Journal of Pharmacology 132 (2–3): 115–21.  
  3. ^ a b Richelson E, Nelson A (July 1984). "Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro". The Journal of Pharmacology and Experimental Therapeutics 230 (1): 94–102.  
  4. ^ a b Cusack B, Nelson A, Richelson E (May 1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology 114 (4): 559–65.  
  5. ^ Odagaki Y, Toyoshima R, Yamauchi T (May 2005). "Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding". Journal of Psychopharmacology (Oxford, England) 19 (3): 235–41.  


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.